ACUTE RENAL FAILURE IN PREGNANCY - PowerPoint PPT Presentation

About This Presentation
Title:

ACUTE RENAL FAILURE IN PREGNANCY

Description:

ACUTE RENAL FAILURE IN PREGNANCY Dr. Mona Shroff, M.D.(O&G) EMOC Advanced Trainer (FOGSI,GOI,JHPIEGO EmOC project) Diploma in O & G Ultrasound (Ian Donald) – PowerPoint PPT presentation

Number of Views:1052
Avg rating:3.0/5.0
Slides: 32
Provided by: obgyntoda
Category:

less

Transcript and Presenter's Notes

Title: ACUTE RENAL FAILURE IN PREGNANCY


1
ACUTE RENAL FAILURE IN PREGNANCY
Dr. Mona Shroff, M.D.(OG)
EMOC Advanced Trainer (FOGSI,GOI,JHPIEGO
EmOC project) Diploma in O G Ultrasound (Ian
Donald)
2
This presentation covers
  • BASIC OUTLINE
  • Investigations
  • MANAGEMENT PRINCIPLES
  • Prerenal Vs ATN Vs ACN
  • ROLE OF Nutrition
  • Volume metabolic control
  • Diuretics helpful or harmful
    ??
  • Dopamine helpful or harmful
    ??
  • Dialysis when which ??
  • Renal biopsy ??
  • Delivery
  • Conditions specific to pregnancy

3
DEFINITIONS OF ARF
  • The syndrome is characterised by a sudden in
    parenchymal function (UOPlt400ml/d30ml/hr) which
    is usually but not always reversible
  • This produces disturbance of water, electrolyte,
    acid base balance and nitrogenous waste products
    blood pressure.

4
Physiological changes in normal gestation
  • Kidney weight and size increase
  • Dilation of renal calyces, pelves, and ureters
  • Urinary stasis
  • Glomerular filtration, effective renal plasma
    flow, fractional clearance of urate increase
  • Bicarbonate reabsorption threshold decreases

5
Clinical relevance
  • Concentrations of serum creatinine, urea N, and
    uric acid of 0.9, 14, and 5.6 mg/dl, normal in
    nonpregnant subjects, are already suspiciously
    high in gravid women.
  • Asymptomatic bacteriuria - frank pyelonephritis.
  • PP reduction in size should not be mistaken for
    parenchymal loss
  • Post renal failure difficult to diagnose
  • S.bicarb lower,PCO2 10 mmHg lower

6
Causes
  • Bimodal distribution -peaks in the first
    trimester (related to unregulated and/or septic
    abortion,hyperemesis) and the late third
    trimester (related to obstetric complications
    APH,PPH,Preeclampsia, Chorioamnionitis,AFE etc).

7
ATN CORTICAL NECROSIS THOMBOTIC
MICROANGIOPATHIES
8
(No Transcript)
9
  • The RIFLE classification (ADQI group) of
    ARF
  • Risk (R) - Increase in serum creatinine level X
    1.5 or decrease in GFR by 25, or UO lt0.5 mL/kg/h
    for 6 hours
  • Injury (I) - Increase in serum creatinine level X
    2.0 or decrease in GFR by 50, or UO lt0.5 mL/kg/h
    for 12 hours
  • Failure (F) - Increase in serum creatinine level
    X 3.0, decrease in GFR by 75, or serum
    creatinine level gt 4 mg/dL UO lt0.3 mL/kg/h for
    24 hours, or anuria for 12 hours
  • Loss (L) - Persistent ARF, complete loss of
    kidney function gt4 wk
  • End-stage kidney disease (E) - Loss of kidney
    function gt3 months

10
PHASES
  • OLIGURIA
  • POLYURIA
  • RECOVERY

11
Investigations
  • BLOOD
  • CBC
  • Urea,creatinine,uric acid
  • Electrolytes
  • LFT
  • S.proteins
  • Coagulation profile
  • ABG
  • RBS
  • Osmolality
  • URINE
  • sp.gravity
  • osmolality
  • electrolytes
  • proteins
  • pigment casts
  • c/s
  • ECG

12
Management
  • Restore or maintain fluid balance
  • The maintenance of electrolytes and acid base
    balance
  • The maintenance of nutritional support
  • Prevention of infection
  • Avoid renal toxins (including NSAIDS)
  • Instigate renal replacement therapies

13
Prerenal failure
  • Adequately replace blood fluid losses,maintain
    BP.
  • Control continuing blood loss
  • Mannitol (100ml, 25) trial to d/d b/w reversible
    prerenal failure established ATN (provided
    oliguria lt48 hrs UP osmolality gt 1.05)
  • If diuresis (gt50ml/hr or doubling) established
    within 3 hrs,maintain NS infusion acc to UOP
    replace electrolytes acc to urinary loss
    estimations.
  • If unsuccessful objective is to support the
    functionally anephric pt till kidneys recover.

14
Volume control
  • IP/OP charting daily
  • State of hydration-wt,hct,protein
  • Input Output/24hrs 500ml(nonfebrile)
  • 200 ml/ deg C of inc. in Tem
  • Balance 0.3-0.5kg wt loss/d
  • Avoid overhydration Rx diuretics,dialysis
  • CVP monitoring (b/w 10-15cm H2O)

15
Diuretics
  • Diuretics commonly have been given
    in an attempt to convert the oliguric state to a
    nonoliguric state. However, diuretics have not
    been shown to be beneficial, and they may worsen
    outcomes.
  • In the absence of compelling contradictory data
    from a randomized, blinded clinical trial, the
    widespread use of diuretics in critically ill
    patients with acute renal failure should be
    discouraged.
  • Useful only in management of fluid-overloaded
    patients

Cantarovich F, Rangoonwala B, Lorenz H, Verho M,
Esnault VL. High-dose furosemide for established
ARF a prospective, randomized, double-blind,
placebo-controlled, multicenter trial. Am J
Kidney Dis 200444402-9. Kellum JA.
Systematic review The use of diuretics and
dopamine in acute renal failure a systematic
review of the evidence. Critical
Care19971(2)539.
16
DOPAMINE
  • Dopamine traditionally has been used to promote
    renal perfusion(1-5 mcg/kg/min )
  • However, systematic reviews of dopamine
    treatment in critically ill patients and in
    patients with sepsis do not support the use of
    dopamine to prevent renal insufficiency,
    morbidity, or mortality. In the majority of ARF
    studies, dopamine was associated only with an
    increase in urine output.

Kellum JA, Decker MJ. Use of dopamine in acute
renal failure a meta-analysis. Crit Care Med
2001291526-31. Denton MD, Chertow GM, Brady
HR. "Renal-dose" dopamine for the treatment of
acute renal failure scientific rationale,
experimental studies and clinical trials. Kidney
Int 1996504-14.
17
Nutrition
  • INTAKE
  • 1500 cal (protein free)
  • Oral/parenteral
  • If vol limitation-50D via central vein
  • Essential L-aminoacids K,Mg,PImprove wound
    healing, hasten recovery
  • Protein intake of 0.6 g per kg per day

18
Electrolyte acid-base correction
  • Hyperkalemia, which can be life-threatening,
    should be treated by
  • decreasing the intake of potassium,
  • delaying the absorption of potassium,
  • exchanging potassium across the gut lumen using
    potassium-binding resins,
  • controlling intracellular shifts
  • dialysis.
  • Acidosis- sodabicarb ,dialysis

19
  • Treat coagulopathy with FFP for a prolonged aPTT,
    cryoprecipitate for a fibrinogen level less than
    100 mg/dL, and transfuse platelets for platelet
    counts less than 20,000/mm3
  • Timely identification of UTI, proper treatment
    prevention using prophylactic antibiotics

20
Indications for Kidney Replacement Therapy
  • Acidosis unresponsive to medical therapy
  • Acute, severe, refractory electrolyte changes
    (e.g., hyperkalemia)
  • Encephalopathy
  • Significant azotemia (blood urea nitrogen level
    gt100 mg per dL 36 mmol per L)
  • Significant bleeding
  • Uremic pericarditis
  • Volume overload

21
Early Prophylactic Dialysis
  • Allows more liberal fluid, protein salt intake.
  • Prevent hyperkalemic emergencies.
  • infectious Cx.
  • Improves comfort survival

22
Hemodialysis Vs Peritoneal
dialysis
  • Limited usefulness if hypotension
  • C/I in actively bleeding pt.
  • Controlled anticoagulation reqd
  • Volume shifts-careful
  • Faster correction
  • Can be used in preg/PP pt.
  • Easily available
  • Simple,inexpensive
  • Lower Cx rate
  • Minimises rapid metabolic pertubations fluid
    shifts
  • Insert cath high direct vision

23
Delivery
  • Development of ARF in obs pt is indication of
    delivery in majority cases.
  • Deliver if UOPlt20 ml/gt2hrs despite adequate vol
    expansion immediate delivery not expected
  • Redistribution of CO better renal perfusion.
  • Remove fetus from hostile environment.
  • Neonate urea osmotis diuresis -dehydration

24
Renal biopsy
  • Potentially v.risky in pregnancy
  • Defer until postpartum even if ACN( for
    prognostication).
  • Rare indication sudden renal failure before 32
    wks with no obvious cause.

25
Preeclampsia
  • A decrease in the GFR occurs secondary to
    intrarenal vasospasm. This may manifest as a
    "prerenal" picture. Acute renal failure (ARF) may
    develop, and acute tubular necrosis (ATN) may
    ensue if this hypoperfusion persists.

26
Pre-eclampsia ManagementRenal problems
  • Hyperuricaemia and proteinuria are NOT
    indications for delivery per se
  • Consider delivery for progressive renal
    impairment (creatinine gt0.09 mmol/L)
  • Care with fluids (pulmonary oedema can kill!)
  • Kidney Function is Criticalfor Drug Elimination

27
Pre-eclampsiaInvasive monitoring
  • CVP monitoring may NOT be helpful!
  • poor correlation between CVP and PCWP
  • PA catheters have risks!
  • rare indications
  • pulmonary oedema resistant to diuretics
  • oliguric renal failure despite volume expansion

28
Idiopathic postpartum renal failure
  • Associated primarily with microangiopathic
    processes
  • Postpartum hemolytic-uremic syndrome.
  • These were often irreversible and were
    associated with substantial mortality.
  • Now improved outcome with plasma
    exchange,dialysis,prostacyclin infusion,
    correcting coagulopathy

29
ACUTE FATTY LIVER OF PREGNANCY
  • Associated with acute renal failure in up to
    60 percent of cases.
  • The diagnosis should be suspected in a woman
    with preeclampsia who has jaundice,hypoglycemia,
    hypofibrinogenemia, and a prolonged PTT in the
    absence of abruptio placentae.

30
KEY RECOMMENDATIONS FOR PRACTICE
  • Identify prevent at prerenal phase as early as
    possible
  • Dopamine should not be used to prevent
  • acute renal failure. (Evidence level A)
  • Diuretics should not be used to treat oliguria in
    patients with acute renal failure unless volume
    overload (Evidence level B)
  • Early prophylactic dialysis should be strongly
    considered.
  • The maintenance of electrolytes,acid base balance
    nutritional support plays vital role.

31
  • THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com